Autobio Diagnostics Co., Ltd.

SHSE:603658 Stock Report

Market Cap: CN¥26.6b

Autobio Diagnostics Future Growth

Future criteria checks 3/6

Autobio Diagnostics is forecast to grow earnings and revenue by 20.9% and 16% per annum respectively. EPS is expected to grow by 20.7% per annum. Return on equity is forecast to be 16.2% in 3 years.

Key information

20.9%

Earnings growth rate

20.7%

EPS growth rate

Medical Equipment earnings growth26.7%
Revenue growth rate16.0%
Future return on equity16.2%
Analyst coverage

Good

Last updated21 Nov 2024

Recent future growth updates

Recent updates

Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Aug 09
Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Could Be 35% Above Their Intrinsic Value Estimate

Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Jul 18
Improved Earnings Required Before Autobio Diagnostics Co., Ltd. (SHSE:603658) Shares Find Their Feet

Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

May 21
Does Autobio Diagnostics (SHSE:603658) Have A Healthy Balance Sheet?

Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Feb 27
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) 27% Price Boost Is Out Of Tune With Earnings

Earnings and Revenue Growth Forecasts

SHSE:603658 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20266,5032,022N/A2,1986
12/31/20255,6211,655N/A1,8749
12/31/20244,7541,347N/A1,6208
9/30/20244,5811,2737101,468N/A
6/30/20244,5431,2915751,429N/A
3/31/20244,4961,3006861,595N/A
12/31/20234,4441,2175691,470N/A
9/30/20234,4031,1696091,501N/A
6/30/20234,4791,1806561,525N/A
3/31/20234,4471,1696311,580N/A
12/31/20224,4421,1676201,558N/A
9/30/20224,3521,1565811,536N/A
6/30/20224,1591,0955081,508N/A
3/31/20223,9801,0423861,384N/A
12/31/20213,7669743951,461N/A
9/30/20213,6269504671,608N/A
6/30/20213,4508871251,339N/A
3/31/20213,245826-231,191N/A
12/31/20202,978748-121995N/A
9/30/20202,833751-361630N/A
6/30/20202,706728-202717N/A
3/31/20202,682746-35797N/A
12/31/20192,67977481843N/A
9/30/20192,46368944754N/A
6/30/20192,261636142685N/A
3/31/20192,062588216650N/A
12/31/20181,930563244654N/A
9/30/20181,777534215566N/A
6/30/20181,666502N/A537N/A
3/31/20181,574475N/A507N/A
12/31/20171,400447N/A482N/A
9/30/20171,271419N/A501N/A
6/30/20171,129393N/A461N/A
3/31/20171,030363N/A444N/A
12/31/2016980350N/A416N/A
9/30/2016898335N/A360N/A
6/30/2016837317N/A371N/A
3/31/2016752278N/A313N/A
12/31/2015716278N/A309N/A
12/31/2014563208N/A257N/A
12/31/2013409124N/A103N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 603658's forecast earnings growth (20.9% per year) is above the savings rate (2.8%).

Earnings vs Market: 603658's earnings (20.9% per year) are forecast to grow slower than the CN market (26.1% per year).

High Growth Earnings: 603658's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 603658's revenue (16% per year) is forecast to grow faster than the CN market (13.9% per year).

High Growth Revenue: 603658's revenue (16% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 603658's Return on Equity is forecast to be low in 3 years time (16.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y